Perceptions of COVID-19 Vaccination in Patients with Genitourinary Cancers: A Survey Study
- Daniela V. Castro (10819116)
- Zeynep B. Zengin (14335361)
- Jasnoor Malhotra (14335364)
- Cristiane D. Bergerot (14335367)
- Luis Meza (13254297)
- Nazli Dizman (6248405)
- Ameish Govindarajan (14335370)
- JoAnn Hsu (572618)
- Alex Chehrazi-Raffle (14335373)
- Neal Chawla (5339402)
- Benjamin D. Mercier (14335376)
- Sean W. Chen (14335379)
- Matthew Feng (14335382)
- Sweta Prajapati (14335385)
- Kyle O. Lee (14335388)
- Errol J. Philip (9210992)
- Tanya B. Dorff (14335391)
- Yung Lyou (260823)
- Sumanta K. Pal (8429904)
Publication date
January 2023
DOIAbstract
Since the approval of the COVID-19 vaccines, their safety and efficacy has been widely demonstrated in patients with cancer. However, there remain patients with reservations regarding vaccination. We aimed to assess genitourinary cancer patients’ perceptions of the vaccines as well as barriers and influencers of decision-making through the completion of a questionnaire. While vaccine-associated concerns were observed, most patients with genitourinary cancers were willing to receive the vaccine. Moving forward, differing strategies could be considered to enhance patient education on the utility of vaccination in the setting of cancer and beyond.</p
Add to ORKG